Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v11-EN Version v6-EN
Language English English
Date Updated 2018-07-14 2018-06-07
Drug Identification Number 02287145 02287145
Brand name FOSRENOL FOSRENOL
Common or Proper name Lanthanum carbonate chewable tablets Lanthanum carbonate chewable tablets
Company Name SHIRE PHARMA CANADA ULC SHIRE PHARMA CANADA ULC
Ingredients LANTHANUM LANTHANUM
Strength(s) 250MG 250MG
Dosage form(s) TABLET (CHEWABLE) TABLET (CHEWABLE)
Route of administration ORAL ORAL
Packaging size 90's 90's
ATC code V03AE V03AE
ATC description ALL OTHER THERAPEUTIC PRODUCTS ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2018-06-06 2018-06-06
Actual start date
Estimated end date 2018-07-20 2018-06-28
Actual end date 2018-07-13
Shortage status Resolved Actual shortage
Company comments
Health Canada comments